Hayley Friedman1, Gregory Parkinson2, Hocine Tighiouart3,4, Catherine Parkinson2, David Tybor5, Norma Terrin3, Barry Lester6, Karen Harvey-Wilkes1, Jonathan M Davis7,8. 1. Division of Newborn Medicine, Tufts Medical Center, Boston, MA, USA. 2. Cape Cod Health, Hyannis, MA, USA. 3. The Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA. 4. The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. 5. School of Public Health, Tufts University School of Medicine, Boston, MA, USA. 6. Department of Pediatrics, Women and Infant's Hospital, Providence, RI, USA. 7. Division of Newborn Medicine, Tufts Medical Center, Boston, MA, USA. jdavis@tuftsmedicalcenter.org. 8. The Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA. jdavis@tuftsmedicalcenter.org.
Abstract
OBJECTIVE: To compare length of hospital stay (LOS), LOS due to neonatal abstinence syndrome (NAS), and duration of pharmacologic treatment in community or academic settings. STUDY DESIGN: One hundred-two infants exposed to opioids in utero at two community hospitals were compared to 256 from eight academic centers. All infants were managed with non-pharmacologic care followed by similar pharmacologic treatment options. RESULTS: Two hundred-twelve infants received pharmacologic treatment for NAS. Mean LOS (24.7 ± 8.5 vs. 24.5 ± 11.3 days), LOS due to NAS (24.0 ± 8.2 vs. 23.3 ± 9.2 days), and duration of NAS treatment (19.3 ± 8.0 vs. 18.9 ± 9.2 days) were similar in community compared to academic medical centers. CONCLUSIONS: No significant differences were found in infants managed in the community compared to academic care settings. These findings support caring for opioid-exposed infants in both community and academic settings with the use of standardized care protocols.
OBJECTIVE: To compare length of hospital stay (LOS), LOS due to neonatal abstinence syndrome (NAS), and duration of pharmacologic treatment in community or academic settings. STUDY DESIGN: One hundred-two infants exposed to opioids in utero at two community hospitals were compared to 256 from eight academic centers. All infants were managed with non-pharmacologic care followed by similar pharmacologic treatment options. RESULTS: Two hundred-twelve infants received pharmacologic treatment for NAS. Mean LOS (24.7 ± 8.5 vs. 24.5 ± 11.3 days), LOS due to NAS (24.0 ± 8.2 vs. 23.3 ± 9.2 days), and duration of NAS treatment (19.3 ± 8.0 vs. 18.9 ± 9.2 days) were similar in community compared to academic medical centers. CONCLUSIONS: No significant differences were found in infants managed in the community compared to academic care settings. These findings support caring for opioid-exposed infants in both community and academic settings with the use of standardized care protocols.
Authors: Lisa Clemans-Cope; Nikhil Holla; Henry C Lee; Allison Shufei Cong; Robert Castro; Lisa Chyi; Angela Huang; Kimá Joy Taylor; Genevieve M Kenney Journal: J Perinatol Date: 2020-01-07 Impact factor: 2.521